CN1075953C - Method for removing blood fat and fibrinogen in blood - Google Patents

Method for removing blood fat and fibrinogen in blood Download PDF

Info

Publication number
CN1075953C
CN1075953C CN 96117098 CN96117098A CN1075953C CN 1075953 C CN1075953 C CN 1075953C CN 96117098 CN96117098 CN 96117098 CN 96117098 A CN96117098 A CN 96117098A CN 1075953 C CN1075953 C CN 1075953C
Authority
CN
China
Prior art keywords
blood
plasma
fibrinogen
freezing
centrifuge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 96117098
Other languages
Chinese (zh)
Other versions
CN1144696A (en
Inventor
欧阳延
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5124035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1075953(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to CN 96117098 priority Critical patent/CN1075953C/en
Publication of CN1144696A publication Critical patent/CN1144696A/en
Application granted granted Critical
Publication of CN1075953C publication Critical patent/CN1075953C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for removing blood fat and fibrinogen in blood, belonging to a blood processing method. The method is characterized in that blood is placed in a blood bag and placed on a centrifugal machine, the centrifugal machine is rotated, the blood bag is taken out after the centrifugal machine stops, separated blood plasma and blood corpuscles are respectively placed in the blood bag, the blood plasma is placed in an ice chamber for freezing, then taken out for thawing, calcium ions are added into the blood plasma after thawing, then the blood plasma is placed in the ice chamber for freezing, then the blood plasma is taken out for dissolving, blood fat immediately emerges, and fibrinogen appears after about 10 minutes. The method can remove blood lipid and fibrinogen in blood, and can prevent arteriosclerosis.

Description

Remove blood fat and Fibrinogen method in the blood
The present invention relates to a kind of processing method of blood.
At present, blood treatment is generally adopted blood quantum therapeutic instrument (" blood quantum therapy " Henan Science Press in 1993), it is that blood is put into blood quantum therapeutic instrument to the blood ultraviolet radiation, charge into oxygen then in blood, this blood processing can not clear out blood fat in the blood and Fibrinogen.
The objective of the invention is to provide a kind of and can remove blood fat and Fibrinogen method in the blood.
The object of the present invention is achieved like this, and blood is placed on the centrifuge, isolates blood plasma and blood cell, with the plasma freezing → calcium ion that thaws → add → freezing → dissolving.
Since adopt such scheme, blood fat in the blood and Fibrinogen conglomerate in blood plasma, and blood fat and Fibrinogen in the blood promptly are eliminated out.This method has been removed blood fat and the Fibrinogen in the blood, can prevent arteriosclerotic generation and development.
The present invention is described in detail for the following examples.
Embodiment: blood is placed disposable sterilized blood bag, be placed on the centrifuge, start centrifuge, 1800 rev/mins of centrifuge speeds rotate shutdown in 7 minutes.Take out the blood bag after the centrifuge stall, the blood plasma and the blood cell of separator well are placed on respectively in the disposable sterilized blood bag, blood plasma was placed in-40 ℃ of icehouses freezing 24 hours, take out after 24 hours and under the condition of flowing water, thaw, back adding 5% calcium chloride in blood plasma thaws, and then inserted-40 ℃ of icehouses interior freezing 24 hours, take out after 24 hours, put in 37 ℃ of tanks of people and dissolve, at this moment blood fat appears in one's mind out immediately, Fibrinogen occurs after about 10 minutes, and dissolving finishes, blood fat and Fibrinogen conglomerate in blood plasma.

Claims (1)

1, blood fat and Fibrinogen method in a kind of removing blood is characterized in that: blood is placed on the centrifuge, isolate blood plasma and blood cell, plasma freezing---is thawed and---adds---freezing---dissolving of calcium ion;
Described method is that blood is placed disposable sterilized blood bag, be placed on the centrifuge, start centrifuge, centrifuge speed is with 1800 rev/mins, rotate shutdown in 7 minutes, take out the blood bag after the centrifuge stall, the blood plasma and the blood cell of separator well is placed on respectively in the disposable sterilized blood bag, blood plasma was placed in-40 ℃ of icehouses freezing 24 hours, take out after 24 hours and under the condition of flowing water, thaw, in blood plasma, add 5% calcium chloride after thawing, and then inserted-40 ℃ of icehouses interior freezing 24 hours, take out after 24 hours, putting into 37 ℃ of tanks dissolves, at this moment blood fat appears in one's mind out immediately, and Fibrinogen occurs after about 10 minutes, and dissolving finishes.
CN 96117098 1996-09-17 1996-09-17 Method for removing blood fat and fibrinogen in blood Expired - Fee Related CN1075953C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96117098 CN1075953C (en) 1996-09-17 1996-09-17 Method for removing blood fat and fibrinogen in blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96117098 CN1075953C (en) 1996-09-17 1996-09-17 Method for removing blood fat and fibrinogen in blood

Publications (2)

Publication Number Publication Date
CN1144696A CN1144696A (en) 1997-03-12
CN1075953C true CN1075953C (en) 2001-12-12

Family

ID=5124035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96117098 Expired - Fee Related CN1075953C (en) 1996-09-17 1996-09-17 Method for removing blood fat and fibrinogen in blood

Country Status (1)

Country Link
CN (1) CN1075953C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038202A1 (en) * 2000-11-09 2002-05-16 Kenneth Allan De Luca Fat extraction
CN100374170C (en) * 2004-05-13 2008-03-12 苏华 Blood treatment device for treating microcirculatory disturbance

Also Published As

Publication number Publication date
CN1144696A (en) 1997-03-12

Similar Documents

Publication Publication Date Title
Runne et al. Short‐duration (‘minutes’) therapy with dithranol for psoriasis: a new out‐patient regimen
NZ597965A (en) Methods of preparing and using stem cell compositions and kits comprising the same
WO2008048663A2 (en) Novel process for devitalized/acellular tissue for transplantation
HK1078009A1 (en) Systems and methods for treating patients with processed lipoaspirate cells
NO142381B (en) PROCEDURE FOR MANUFACTURING THE ANTIHEMOFILE FACTOR
Fraedrich et al. Instillation of fibrinolytic enzymes in the treatment of pleural empyema
CN1075953C (en) Method for removing blood fat and fibrinogen in blood
Dyckner et al. Magnesium deficiency contributing to ventricular tachycardia: Two case reports
Palmer et al. Button battery in the nose–an unusual foreign body
Lumb et al. Changes in plasma folate levels in rats inhaling nitrous oxide
Moorhead et al. Human red cell concentrate for surgical dressings
CN108715612A (en) The preparation method of fish collagen antioxidant peptide
Hellgren Cleansing properties of stabilized trypsin and streptokinase-streptodornase in necrotic leg ulcers
US6932966B1 (en) Topically applied reconstituted ocean water mixture and method of producing and using the mixture
RU2196603C2 (en) Method for treating the cases of burning disease
CN110772445A (en) Skin whitening oligopeptide composition and preparation method thereof
CN108404240A (en) Blood processing is carried out using blood quantum therapeutic device
Zierski Prospects of retreatment of chronic resistant pulmonary tuberculosis patients. A critical review
CN110127151A (en) It is a kind of for remove dialysis articles packaging in sterilizing gas method and device
Lie et al. Successful treatment of hepatic coma by a new artificial liver device in the pig
JPH11285539A (en) Magnetic medical treating equipment
CN108904433A (en) The penetrating fluid and preparation method thereof of moisture separation process in fat cell
Michaeli et al. Severe hypertension and lithium intoxication
KR101005938B1 (en) Preparing and Devise for scaffold
JPS56115720A (en) Prophylactic agent for pigling

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee